Somaxon Pharmaceuticals Inc (SOMX)

Somaxon focuses on making drugs that fight psychiatric and neurological diseases. Silenor, for example, fights insomnia. They've also got products in the pipeline to help with quitting smoking, and even gambling.

Show Chart

Events

  • March 22012
    Somaxon Pharmaceuticals, Inc. expected to report Fiscal Year 2011 results on March 2, 2012. This event was calculated by Capital IQ (Created on November 5, 2011).

Members who own this company also own

Current price per share


Today's gain: $-0.02 (-3.20%)

Is this a fair price given publicly available information?
(Not an indicator of whether the price will go up or down.)
Close Icon